Response to: 'Achieving lupus low disease activity and remission states under belimumab in refractory systemic lupuserythematosus: time and organ involvement matter' by Sbeih et al

Journal article

M Nikpour, M Huq, S Oon

Annals of the Rheumatic Diseases | BMJ PUBLISHING GROUP | Published : 2020

The multi-organ autoimmune diseases ‘scleroderma’ and ‘lupus’ have a profound negative impact on quality of life and life expectancy. The ov..

MN holds a National Health and Medical Research Council of Australia (NHMRC) Career Development Fellowship (APP1126370).